GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medrx Co Ltd (TSE:4586) » Definitions » Shiller PE Ratio

Medrx Co (TSE:4586) Shiller PE Ratio : (As of Jun. 24, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Medrx Co Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Medrx Co Shiller PE Ratio Historical Data

The historical data trend for Medrx Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medrx Co Shiller PE Ratio Chart

Medrx Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medrx Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Medrx Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Medrx Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medrx Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medrx Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Medrx Co's Shiller PE Ratio falls into.



Medrx Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Medrx Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Medrx Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-3.33/107.2000*107.2000
=-3.330

Current CPI (Mar. 2024) = 107.2000.

Medrx Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -40.620 98.000 -44.433
201409 -34.810 98.500 -37.885
201412 -30.310 97.900 -33.189
201503 -20.110 97.900 -22.020
201506 -30.210 98.400 -32.912
201509 -29.120 98.500 -31.692
201512 -51.770 98.100 -56.572
201603 -33.330 97.900 -36.496
201606 -58.770 98.100 -64.222
201609 -33.945 98.000 -37.132
201612 -30.837 98.400 -33.595
201703 -22.610 98.100 -24.707
201706 -33.510 98.500 -36.470
201709 -27.530 98.800 -29.871
201712 -19.510 99.400 -21.041
201803 -31.130 99.200 -33.640
201806 -27.381 99.200 -29.589
201809 -36.270 99.900 -38.920
201812 -32.060 99.700 -34.472
201903 -45.010 99.700 -48.396
201906 -32.130 99.800 -34.512
201909 -25.847 100.100 -27.680
201912 -32.440 100.500 -34.603
202003 -20.930 100.300 -22.370
202006 -26.180 99.900 -28.093
202009 -15.950 99.900 -17.116
202012 -6.866 99.300 -7.412
202103 -13.370 99.900 -14.347
202106 -10.570 99.500 -11.388
202109 -8.990 100.100 -9.628
202112 -16.690 100.100 -17.874
202203 -8.010 101.100 -8.493
202206 -7.490 101.800 -7.887
202209 -10.320 103.100 -10.730
202212 -17.990 104.100 -18.526
202303 -9.610 104.400 -9.868
202306 -5.438 105.200 -5.541
202309 -5.030 106.200 -5.077
202312 -6.820 106.800 -6.846
202403 -3.330 107.200 -3.330

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medrx Co  (TSE:4586) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Medrx Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Medrx Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medrx Co (TSE:4586) Business Description

Traded in Other Exchanges
N/A
Address
431-7 Nishiyama, Higashikagawa, Kagawa, JPN, 769-2712
Medrx Co Ltd is a pharmaceutical drug development company founded in January, 2002. The Company engaged in the research and development of pharmaceutical products utilizing the pharmaceutical formulation technology based on ionic liquid transdermal system. The Company develops new pharmaceutical candidates and licenses other companies to produce the pharmaceuticals after clinical trials. Its main products include analgesic patches for anti-inflammatory and pain relief.

Medrx Co (TSE:4586) Headlines

No Headlines